ADTX Company Profile and Key Details
NASDAQ : ADTX
Aditxt
$0.01
0.0002+1.57%
Open: 2:36 PM66.54
BESG ScoreESG Rating
Price Chart
Stock Price Today
Aditxt, Inc. (ADTX) stock surged +1.57%, trading at $0.01 on NASDAQ, up from the previous close of $0.01. The stock opened at $0.01, fluctuating between $0.01 and $0.02 in the recent session.
Stock Snapshot
0.0127
Prev. Close
432
Market Cap
0.0113
Day Low
N/A
P/E Ratio
-1380.8
EPS (TTM)
-14.1
Cash Flow per Share
0.01
Open
33.5K
Number of Shares
0.0165
Day High
100%
Free Float in %
12.17
Book Value
613.72M
Volume
Relevant Articles
SEC Fillings
Current Report (8-k)
| Filing Date | Accepted Date | |
|---|---|---|
Annual Report (10-k)
| Filing Date | Accepted Date | |
|---|---|---|
Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 12, 2026 | 0.02 | 0.02 | 0.01 | 0.01 | 1.22B |
| Jun 11, 2026 | 0.02 | 0.02 | 0.01 | 0.01 | 628.83M |
| Jun 10, 2026 | 0.02 | 0.02 | 0.02 | 0.02 | 229.8M |
| Jun 09, 2026 | 0.04 | 0.04 | 0.03 | 0.03 | 393.19M |
| Jun 08, 2026 | 0.05 | 0.05 | 0.05 | 0.05 | 34.67M |
| Jun 05, 2026 | 0.07 | 0.07 | 0.06 | 0.06 | 30.02M |
| Jun 04, 2026 | 0.08 | 0.09 | 0.07 | 0.08 | 26.28M |
| Jun 03, 2026 | 0.10 | 0.11 | 0.09 | 0.09 | 28.42M |
| Jun 01, 2026 | 0.10 | 0.15 | 0.09 | 0.11 | 30.95M |
| May 29, 2026 | 0.16 | 0.22 | 0.11 | 0.12 | 58.35M |
| May 28, 2026 | 0.17 | 0.17 | 0.15 | 0.16 | 5.69M |
| May 27, 2026 | 0.20 | 0.22 | 0.18 | 0.20 | 5.32M |
| May 26, 2026 | 0.34 | 0.36 | 0.23 | 0.25 | 7.94M |
| May 22, 2026 | 0.79 | 0.85 | 0.47 | 0.51 | 12.59M |
| May 21, 2026 | 1.40 | 1.44 | 1.11 | 1.22 | 306.53K |
| May 20, 2026 | 1.50 | 1.52 | 1.34 | 1.40 | 216.37K |
| May 19, 2026 | 1.49 | 1.89 | 1.45 | 1.52 | 700.97K |
| May 18, 2026 | 1.90 | 1.93 | 1.41 | 1.63 | 382.48K |
| May 15, 2026 | 1.89 | 1.97 | 1.51 | 1.71 | 875.96K |
| May 14, 2026 | 1.73 | 2.09 | 1.59 | 1.80 | 359.05K |
Contact Details
About Company
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.
Company Information
| Employees | 26 |
| Beta | 1.51 |
| Sales or Revenue | $645.18K |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Stock Peers
ARGX
-5.42-0.60%
argenx SE$893.52REGN0.66+0.11%
Regeneron Pharmaceuticals, Inc.$612.14UTHR0.56+0.10%
United Therapeutics Corporation$545.96MDGL6.49+1.37%
Madrigal Pharmaceuticals, Inc.$480.77VRTX-0.115-0.03%
Vertex Pharmaceuticals Incorporated$444.93KRTX0.09+0.03%
Karuna Therapeutics, Inc.$329.83KRYS-3.575-1.11%
Krystal Biotech, Inc.$317.97ALNY-6.54-2.26%
Alnylam Pharmaceuticals, Inc.$282.85PRAX18.6+7.50%
Praxis Precision Medicines, Inc.$266.58LGND0.97+0.38%
Ligand Pharmaceuticals Incorporated$255.54Company Overview
The stock is currently mid-range between its 52-week high and low $0.01 and $53.45 thousand. With a market capitalization of about $449.00, Aditxt, Inc. is classified as a micro-cap and shows market-like volatility (beta ~0.81). Key stats such as the average daily volume over the past year has been around 44.76 million shares, trading with heavier-than-usual volume. Headquartered in Mountain View, VA, Aditxt, Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Amro A. Albanna, the company employs approximately 26 people and listed since June 30, 2020. Aditxt, Inc. is a biotechnology firm dedicated to advancing immune system health through innovative mapping and reprogramming techniques.
Technical Performance
ADTX has shown mixed momentum, gaining 44.82% over the past week and -96.8% over the past quarter, though year-to-date performance is up 41.4%. Short-term trend indicators are bullishly aligned (SMA20 -24.81%, SMA50 -45.72%, SMA200 -99.36%). The stock’s 14-day RSI is 26.98 (weak momentum), while the ATR of 0.14 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -99.98% below its high and over -4.12% above its low. Average 10-day trading volume of 422.12 million shares is significantly above the 3-month average of 46.81 million, indicating heightened recent market interest.
Valuation Metrics
Aditxt, Inc. trades at a P/E ratio of -0.0, slightly below the S&P 500 average, with a price-to-sales ratio of 0.03 The P/FCF stands at -0.0, also above market averages.
Dividend & Fair Value
Dividend and splits history remains an important factor for investors monitoring long-term returns.
Earnings & Analyst Outlook
Aditxt, Inc. generated EPS of -$6,410.45 over the past year. Five-year average earnings growth is 83.15%. Aditxt, Inc. earnings surprise history is a mixed track record. The quarter that ended May 20, 2026, missed forecasts by -100.0%. The prior quarter beat by -100.0%. Over the last six quarters, Apple has recorded several small beats. These include 174.47% in May 20, 2024.
Shareholding & Insider Activity
Aditxt, Inc. has 815.92 thousand shares outstanding. The public float is 815.92 thousand shares, elevated short interest at 11.44% of float. This equals 93.34 thousand shares. The short ratio is 0.03 days. Institutional investors hold 0.02% of the float. Insiders own 0.0%. Shabahang Shahrokh holds 1.02 million shares, Albanna Rowena has 748.72 thousand shares and BNP PARIBAS SECURITIES CORP has 22.34 thousand shares. Over the past six months, insider transactions show net selling. They sold 4.59 million shares across 8 transactions.
Financial & Profitability Overview
On valuation metrics, Aditxt trades at a P/E of -0.00, P/S of 0.03 and P/B of -0.00. Liquidity is tight, with a current ratio of 0.06 and quick ratio of 0.05. Operationally, the company’s inventory turnover is 0.09 and cash conversion cycle is -241260.71 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is -0.13, supported by a cash flow-to-debt ratio of -4.38.
Quarterly Financial Highlights
The company ended the quarter with $97.10K in cash and short-term investments, a total debt of $18.07M, and net debt of $17.97M. Total assets were $44.58M, with equity of $16.05M. Financials further reflected weakness, with operating cash flow of - $18.58M, free cash flow of - $18.59M, and capital expenditures of - $14.41K.
Price Forecast & Outlook
Our AI price prediction model suggests that Aditxt, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -100.0%, with price expected at $0.00 by June 26, 2026, within a range of $0.00 to $0.00 3-Month Outlook: Projected rise of 372577.17%, reaching $47.33 by September 10, 2026, with a range of $0.00 to $2.11 million. 1-Year Outlook: Projected gain of 19491317.32%, with price at $2.48 thousand by June 11, 2027, within a range of $0.00 to $146.55 million.
Frequently Asked Questions
What is the current Aditxt, Inc. (ADTX) stock price?
Aditxt, Inc. (NASDAQ: ADTX) stock price is $0.01 in the last trading session. During the trading session, ADTX stock reached the peak price of $0.02 while $0.01 was the lowest point it dropped to. The percentage change in ADTX stock occurred in the recent session was 1.57% while the dollar amount for the price change in ADTX stock was $0.00.
ADTX's industry and sector of operation?
The NASDAQ listed ADTX is part of Biotechnology industry that operates in the broader Healthcare sector. Aditxt, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of ADTX?
Dr. Dolly B. Tyan Ph.D.
Senior Vice President of Clinical Devel. Transplantation
Mr. Amro A. Albanna
Co-Founder, Chairman & Chief Executive Officer
Ms. Corinne D. Pankovcin CPA, CPA, M.B.A.
Pres
Mr. Matthew M. Shatzkes
Chief Legal Officer & Gen. Counsel
Ms. Rowena Albanna
Chief Operating Officer
Mr. Thomas J. Farley CPA
Chief Financial Officer
Ms. Maureen Connolly
Chief Content & Engagement Officer
Ms. Corinne D. Pankovcin C.P.A., CPA, M.B.A.
Chief Commercialization Officer
Mr. Ge Chen M.D., M.S.
Senior Vice President of Preclinical Research & Discovery
Dr. Shahrokh Shabahang D.D.S., M.S., Ph.D.
Co-Founder, Chief Innovation Officer, Sec. & Director
Mr. Matthew M. Shatzkes Esq.
Chief Legal Officer, Gen. Counsel & Corporation Sec.
Senior Vice President of Clinical Devel. Transplantation
Mr. Amro A. Albanna
Co-Founder, Chairman & Chief Executive Officer
Ms. Corinne D. Pankovcin CPA, CPA, M.B.A.
Pres
Mr. Matthew M. Shatzkes
Chief Legal Officer & Gen. Counsel
Ms. Rowena Albanna
Chief Operating Officer
Mr. Thomas J. Farley CPA
Chief Financial Officer
Ms. Maureen Connolly
Chief Content & Engagement Officer
Ms. Corinne D. Pankovcin C.P.A., CPA, M.B.A.
Chief Commercialization Officer
Mr. Ge Chen M.D., M.S.
Senior Vice President of Preclinical Research & Discovery
Dr. Shahrokh Shabahang D.D.S., M.S., Ph.D.
Co-Founder, Chief Innovation Officer, Sec. & Director
Mr. Matthew M. Shatzkes Esq.
Chief Legal Officer, Gen. Counsel & Corporation Sec.
How ADTX did perform over past 52-week?
ADTX's closing price is 6.72% higher than its 52-week low of $0.01 where as its distance from 52-week high of $53,453.52 is -100%.
How many employees does ADTX have?
Number of ADTX employees currently stands at 26.
Link for ADTX official website?
Official Website of ADTX is: https://www.aditxt.com
How do I contact ADTX?
ADTX could be contacted at phone 909 488 0844 and can also be accessed through its website. ADTX operates from 737 North Fifth Street, Mountain View, VA 23219, United States.
How many shares of ADTX are traded daily?
ADTX stock volume for the day was 613.72M shares. The average number of ADTX shares traded daily for last 3 months was 44.76M.
What is the market cap of ADTX currently?
The market value of ADTX currently stands at $432.00 with its latest stock price at $0.01 and 33.5K of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep